The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · Real-Time Price · USD
3.030
-0.200 (-6.19%)
At close: Dec 5, 2025, 4:00 PM EST
3.040
+0.010 (0.33%)
After-hours: Dec 5, 2025, 7:03 PM EST
The Oncology Institute Stock Forecast
Stock Price Forecast
The 3 analysts that cover The Oncology Institute stock have a consensus rating of "Strong Buy" and an average price target of $6.00, which forecasts a 98.02% increase in the stock price over the next year. The lowest target is $5.00 and the highest is $7.00.
Price Target: $6.00 (+98.02%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for The Oncology Institute stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 2 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 1 | 1 | 1 | 2 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +65.02% | Nov 25, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +131.02% | Oct 21, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +98.02% | Jul 16, 2025 |
| Jefferies | Jefferies | Strong Buy Initiates $2.5 | Strong Buy | Initiates | $2.5 | -17.49% | Feb 26, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $3 → $2 | Strong Buy | Maintains | $3 → $2 | -33.99% | Jun 16, 2023 |
Financial Forecast
Revenue This Year
505.58M
from 393.41M
Increased by 28.51%
Revenue Next Year
624.58M
from 505.58M
Increased by 23.54%
EPS This Year
-0.56
from -0.71
EPS Next Year
-0.26
from -0.56
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 528.4M | 693.2M | |
| Avg | 505.6M | 624.6M | |
| Low | 488.0M | 591.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 34.3% | 37.1% | |
| Avg | 28.5% | 23.5% | |
| Low | 24.1% | 17.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.54 | -0.18 | |
| Avg | -0.56 | -0.26 | |
| Low | -0.61 | -0.30 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.